Cantargia AB (publ) CANTA.ST Stock
Cantargia AB (publ) Price Chart
Cantargia AB (publ) CANTA.ST Financial and Trading Overview
| Cantargia AB (publ) stock price | 4.13 SEK |
| Previous Close | 3.95 SEK |
| Open | 3.92 SEK |
| Bid | 3.97 SEK x 0 |
| Ask | 3.99 SEK x 0 |
| Day's Range | 3.9 - 4.04 SEK |
| 52 Week Range | 2.98 - 9.46 SEK |
| Volume | 298.66K SEK |
| Avg. Volume | 513.06K SEK |
| Market Cap | 733.28M SEK |
| Beta (5Y Monthly) | 1.576 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.4 SEK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 14.25 SEK |
CANTA.ST Valuation Measures
| Enterprise Value | 524.95M SEK |
| Trailing P/E | N/A |
| Forward P/E | -2.957037 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 3.6192203 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -1.729 |
Trading Information
Cantargia AB (publ) Stock Price History
| Beta (5Y Monthly) | 1.576 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 9.46 SEK |
| 52 Week Low | 2.98 SEK |
| 50-Day Moving Average | 3.85 SEK |
| 200-Day Moving Average | 4.74 SEK |
CANTA.ST Share Statistics
| Avg. Volume (3 month) | 513.06K SEK |
| Avg. Daily Volume (10-Days) | 527.6K SEK |
| Shares Outstanding | 183.69M |
| Float | 181.25M |
| Short Ratio | N/A |
| % Held by Insiders | 7.56% |
| % Held by Institutions | 25.54% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | September 30, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -49.067% |
| Return on Equity (ttm) | -90.16% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -303552992 SEK |
| Net Income Avi to Common (ttm) | -299375008 SEK |
| Diluted EPS (ttm) | -1.71 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 200.24M SEK |
| Total Cash Per Share (mrq) | 1.09 SEK |
| Total Debt (mrq) | 0 SEK |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 4.186 |
| Book Value Per Share (mrq) | 1.103 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -291782016 SEK |
| Levered Free Cash Flow (ttm) | -189592368 SEK |
Profile of Cantargia AB (publ)
| Country | Sweden |
| State | N/A |
| City | Lund |
| Address | Ideon Gateway |
| ZIP | 223 63 |
| Phone | 46 4 62 75 62 60 |
| Website | https://www.cantargia.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 23 |
Cantargia AB (publ), a biotechnology company, engages in the research and development of antibody-based treatments for life threatening diseases. The company is developing CAN04 (Nadunolimab), an interleukin-1 receptor accessory protein (IL1RAP) binding antibody, which is in Phase II clinical trial for the treatment of pancreatic cancer and non-small cell lung cancer, as well as Phase Ib/II for the treatment of triple-negative breast cancer; and CAN10, an antibody against IL1RAP, which is in preclinical phase for the treatment of treatment of autoimmune and inflammatory diseases, including systemic sclerosis and myocarditis. It is also developing CANxx, an IL1RAP-based antibody platform. The company has collaboration agreements with Patheon Biologics B.V. and BioWa Inc. for the manufacture and production of CAN04; Allucent for the clinical study of CAN04; and Pancreatic Cancer Action Network, as well as GEICAM, Spanish breast cancer group. Cantargia AB (publ) was incorporated in 2009 and is based in Lund, Sweden.
Q&A For Cantargia AB (publ) Stock
What is a current CANTA.ST stock price?
Cantargia AB (publ) CANTA.ST stock price today per share is 4.13 SEK.
How to purchase Cantargia AB (publ) stock?
You can buy CANTA.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cantargia AB (publ)?
The stock symbol or ticker of Cantargia AB (publ) is CANTA.ST.
Which industry does the Cantargia AB (publ) company belong to?
The Cantargia AB (publ) industry is Biotechnology.
How many shares does Cantargia AB (publ) have in circulation?
The max supply of Cantargia AB (publ) shares is 183.69M.
What is Cantargia AB (publ) Price to Earnings Ratio (PE Ratio)?
Cantargia AB (publ) PE Ratio is now.
What was Cantargia AB (publ) earnings per share over the trailing 12 months (TTM)?
Cantargia AB (publ) EPS is -1.4 SEK over the trailing 12 months.
Which sector does the Cantargia AB (publ) company belong to?
The Cantargia AB (publ) sector is Healthcare.
Cantargia AB (publ) CANTA.ST included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| OMX Stockholm_GI OMXSGI | 487.13 SEK 47.55 USD |
-1.49
|
— — | 487.13 SEK 47.55 USD | 493.17 SEK 48.14 USD | — - | — — |
| OMX_Nordic_Small_Cap_SEK_GI OMXNSCSEKGI | 452.77 SEK 44.2 USD |
+0.24
|
— — | 451.78 SEK 44.1 USD | 453.92 SEK 44.31 USD | — - | — — |
| OMX_Nordic_Small_Cap_EUR_GI OMXNSCEURGI | 365.72 EUR 399.78 USD |
-0.2
|
— — | 365.63 EUR 399.69 USD | 366.81 EUR 400.97 USD | — - | — — |
| OMX Affarsvarldens Generalindex OMXAFGX | 956.49 SEK 93.37 USD |
-1.49
|
— — | 956.49 SEK 93.37 USD | 968.23 SEK 94.51 USD | — - | — — |
| NASDAQ OMX Small Cap Sweden GI NOMXSCSEGI | 4397.78 SEK 429.28 USD |
-1.5
|
— — | 4397.78 SEK 429.28 USD | 4461.56 SEK 435.5 USD | — - | — — |
| OMX Stockholm Health Care PI SX20PI | 3511.58 SEK 342.77 USD |
-1
|
— — | 3511.58 SEK 342.77 USD | 3555.71 SEK 347.08 USD | — - | — — |
| OMX Stockholm Pharmaceuticals a SX201030PI | 5573.44 SEK 544.04 USD |
-0.81
|
— — | 5573.44 SEK 544.04 USD | 5573.44 SEK 544.04 USD | — - | — — |
| OMX_Stockholm_Small_Cap_PI OMXSSCPI | 1262.91 SEK 123.28 USD |
+0.59
|
— — | 1255.7 SEK 122.57 USD | 1265.8 SEK 123.56 USD | — - | — — |
| OMX Stockholm_PI OMXSPI | 980.59 SEK 95.72 USD |
-1.49
|
— — | 980.59 SEK 95.72 USD | 992.75 SEK 96.9 USD | — - | — — |
| OMX Stockholm All-Share Cap_GI OMXSCAPGI | 477.13 SEK 46.57 USD |
-1.49
|
— — | 477.13 SEK 46.57 USD | 483.05 SEK 47.15 USD | — - | — — |
| OMX_Nordic_Small_Cap_ISK_GI OMXNSCISKGI | 538.42 ISK 3.96 USD |
-0.06
|
— — | 537.03 ISK 3.95 USD | 539.51 ISK 3.97 USD | — - | — — |
| OMX_Nordic_Small_Cap_DKK_GI OMXNSCDKKGI | 365.88 DKK 53.65 USD |
-0.2
|
— — | 365.8 DKK 53.63 USD | 366.99 DKK 53.81 USD | — - | — — |
| NASDAQ OMX Small Cap Sweden PI NOMXSCSEPI | 2732.06 SEK 266.68 USD |
-1.5
|
— — | 2732.06 SEK 266.68 USD | 2771.68 SEK 270.55 USD | — - | — — |
| OMX Stockholm Health Care PI SX4000PI | 2712.52 SEK 264.78 USD |
<0.01
|
— — | — — | — — | — - | — — |
| OMX Stockholm Health Care GI SX20GI | 4524.33 SEK 441.63 USD |
-1
|
— — | 4524.33 SEK 441.63 USD | 4581.2 SEK 447.18 USD | — - | — — |
| OMX Stockholm Pharmaceuticals a SX201030GI | 7565.06 SEK 738.44 USD |
-0.81
|
— — | 7565.06 SEK 738.44 USD | 7565.06 SEK 738.44 USD | — - | — — |
| OMX_Stockholm_Small_Cap_GI OMXSSCGI | 636.84 SEK 62.16 USD |
+0.59
|
— — | 633.21 SEK 61.81 USD | 638.3 SEK 62.31 USD | — - | — — |
- {{ link.label }} {{link}}